Galecto Appoints Dr. Amy Wechsler to Board
Company Announcements

Galecto Appoints Dr. Amy Wechsler to Board

Galecto ( (GLTO) ) has issued an announcement.

Galecto, Inc. has strengthened its Board of Directors by appointing Dr. Amy Wechsler, a distinguished physician with board certifications in dermatology and psychiatry. Her expertise is expected to contribute significantly to Galecto’s mission of developing novel cancer and liver disease treatments. As a non-employee director, she will receive compensation in line with the company’s policy, while bringing valuable experience from her previous roles, including at Bausch Health.

Find detailed analytics on GLTO stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskGalecto, Inc.’s Strategic Shift to Oncology and Liver Diseases: Navigating Risks and Opportunities
TipRanks Auto-Generated NewsdeskGalecto, Inc. Announces Strategic Shift and Financial Overview
TheFlyGalecto reports Q3 EPS ($3.39) vs ($7.50)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App